bioRxiv · 10.1101/2020.06.15.152587
Microscopy-based assay for semi-quantitative detection of SARS-CoV-2 specific antibodies in human sera
Abstract
Emergence of the novel pathogenic coronavirus SARS-CoV-2 and its rapid pandemic spread presents numerous questions and challenges that demand immediate attention. Among these is the urgent need for a better understanding of humoral immune response against the virus as a basis for developing public health strategies to control viral spread. For this, sensitive, specific and quantitative serological assays are required. Here we describe the development of a semi-quantitative high-content microscopy-based assay for detection of three major classes (IgG, IgA and IgM) of SARS-CoV-2 specific antibodies in human samples. The possibility to detect antibodies against the entire viral proteome together with a robust semi-automated image analysis workflow resulted in specific, sensitive and unbiased assay which complements the portfolio of SARS-CoV-2 serological assays. The procedure described here has been used for clinical studies and provides a general framework for the application of quantitative high-throughput microscopy to rapidly develop serological assays for emerging virus infections.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Pape, C., Remme, R., Wolny, A., Olberg, S., Wolf, S., Cerrone, L., Cortese, M., Klaus, S., Lucic, B., Ullrich, S., Anders-Össwein, M., Berati, C., Neufeld, C., Ganter, M., Schnitzler, P., Merle, U., Lusic, M., Boulant, S., Stanifer, M., Bartenschlager, R., Hamprecht, F. A., Kreshuk, A., Tischer, C., Kräusslich, H.-G., Müller, B., Laketa, V.. 2020-06-15. Microscopy-based assay for semi-quantitative detection of SARS-CoV-2 specific antibodies in human sera. https://doi.org/10.1101/2020.06.15.152587
Cite the original work for its findings. Save a collection to share your selection of sources.